Vijaya Kumar
Vijaya Kumar Adla, Warangal IN
Patent application number | Description | Published |
---|---|---|
20100036164 | PREPARATION OF ARMODAFINIL FORM I - Preparation of armodafinil crystalline Form I. Also provided is armodafinil having about 30% or more by weight of particles with sizes greater than about 250 μm, and about 70% or less by weight of particles having sizes less than about 250 μm, wherein of the particles having sizes less than about 250 μm, about 50% of them have diameters less than about 50 μm. | 02-11-2010 |
20110218360 | PREPARATION OF RASAGILINE AND SALTS THEREOF - The present invention relates to processes for the preparation of rasagiline mesylate. Also provided is rasagiline mesylate having 90 volume percent of the particles (D | 09-08-2011 |
Vijaya Kumar Ambati, Hyderabad IN
Patent application number | Description | Published |
---|---|---|
20140297774 | SYSTEM FOR MANAGING CONFIGURATION UPDATES IN CLUSTER OF COMPUTATIONAL DEVICES - A system for managing configuration updates in a cluster of computational devices that includes a master device and a set of participant devices. The master device receives a first configuration command from a user, executes it and updates a configuration version number to a current configuration version number. Thereafter, the master device transmits a multicast message including the current configuration version number to the participant devices. A first participant device sends a configuration request to the master device for transmitting the first configuration command. Thereafter, the first participant device receives the first configuration command from the master device and updates its configuration version number to the current configuration version number. | 10-02-2014 |
Vijaya Kumar Dadala, Hyderabad IN
Patent application number | Description | Published |
---|---|---|
20110040486 | Method for standardization of chemical and therapeutic values of foods and medicines using animated chromatographic fingerprinting - The present invention provides a method of standardization of chemical and therapeutic properties and quality of foods and medicines. The present invention provides a method of chromatographic finger printing facilitating correlation of traditional methods used for chemical and therapeutic standardization of medicines and humors in the living things with physico chemical properties of the medicines and their constituents. The method is used for the qualitative and quantitative analysis of the energy involved in the medicines and living things and to understand various bio chemical reactions in living things using an energy system. It provides a rational basis to understand the traditional methods of assessment of chemical and therapeutic qualities of materials used for the said purpose. The present invention also provides the influence, of factors like pH, temperature, viscosity and ionic nature of the media along with atomic and molecular properties indicating the chemical and therapeutic values of the foods and medicines of natural and synthetic nature. The analysis of biological samples like blood indicated the utility of the method for the assessment of clinical pathological conditions of healthy and diseased. This facilitates for a better drug discovery, drug monitoring, drug targeting and drug profiling using different features of 3-D animated energy box created after analyzing the sample by different analysis, separation and detection methods. | 02-17-2011 |
Vijaya Kumar Dadala, Andhra Pradesh IN
Patent application number | Description | Published |
---|---|---|
20090232706 | Novel method for chromatographic finger printing and standardization of single medicines and formulations - The present invention provides a method for the chromatographic fingerprinting, chemical and therapeutic standardization, bar-coding of the fingerprints and preparation of a data base for Enterprise Resource Planning (ERP) and Customer Relationship Management (CRM) machines and applications of medicines in general and traditional medicines in particular; this invention includes a software based instrumental method and a novel method of fingerprinting and standardization is proposed for the above purpose and the said method for the chromatographic finger printing which facilitates to correlate the traditional therapeutic standardization methods with the chemical properties of the medicines and humors and provides a rational basis to understand the methods used for the said purpose. | 09-17-2009 |
Vijaya Kumar Kilari, Kasturi Nagar IN
Patent application number | Description | Published |
---|---|---|
20130254511 | Improving Storage Lifetime Using Data Swapping - A memory management system for managing memory of a processing system having a primary memory and at least one secondary memory is disclosed. The memory is managed by optimizing the number of writes required by swapping one or more relevant pages of an application from the primary memory to the at least one secondary memory. The system comprises of a dynamic memory manager for allocating memory to the application from a memory pool and having a first table containing virtual addresses and chunk sizes of memory allocated by the application. The system further comprises of a swap manager having a second table containing the physical addresses of the primary memory pages and information whether the pages are allocated or not. The system further comprises of a memory management unit having a third table containing a mapping information of the physical addresses and the virtual addresses of the one or more physical pages used by the application and information whether the page is dirty or not. | 09-26-2013 |
Vijaya Kumar Kilari, Kasturi Naga IN
Patent application number | Description | Published |
---|---|---|
20130326170 | Methods and Devices for Reducing Compressed Page Loading Time on Page Fault - Exemplary embodiments provide for compressing, storing, retrieving and decompressing paged code from mass storage devices. By evaluating the size of compressed virtual pages relative to the storage page (read unit) of the mass storage device into which the compressed virtual pages are to be stored, decisions can be made which facilitate later read out and decompression of those compressed virtual pages. According to exemplary embodiments, a virtual page can be stored uncompressed, compressed but undivided or compressed and subdivided into a plurality of parts based on an evaluation. | 12-05-2013 |
Vijaya Kumar Patnana, Visakhapatnam IN
Patent application number | Description | Published |
---|---|---|
20130306317 | DEGRADABLE POLYMER AND LEGUME PARTICULATES FOR WELL TREATMENT - A method of treating a treatment zone in a well is provided, the method including the steps of: (A) forming a treatment fluid comprising: (i) a degradable polymer particulate; (ii) a legume particulate; and (iii) a continuous liquid phase; and (B) introducing the treatment fluid into the treatment zone of the well. The invention can be used, for example, for leak-off control or fluid diversion purposes. | 11-21-2013 |
20140353042 | Self-Triggering Lost Circulation Control in Carbonate Formation - A self-triggering, in-situ crosslinking fluid system is provided for controlling lost circulation for drilling in a carbonate formation. Methods of drilling a well include the steps of: (A) forming a drilling fluid comprising an aqueous phase, wherein the aqueous phase comprises: (i) water; (ii) acid, wherein the acid is at least sufficiently strong and in at least a sufficient concentration such that the aqueous phase has an initial pH of less than about 2; (iii) a viscosity-increasing agent; and (iv) a crosslinker, wherein the crosslinker is selected or controlled to crosslink the viscosity-increasing agent at a pH range anywhere in a range of about 1.5 to about 6.5 and that is at least higher than the initial pH of the aqueous phase; and (B) drilling with the drilling fluid to form a wellbore penetrating a subterranean formation. | 12-04-2014 |
20140367099 | Degradation of Polylactide in a Well Treatment - Methods of treating a portion of a well include the steps of: (A) depositing a solid particulate into the portion of the well, wherein the solid particulate comprises an aliphatic polyester, preferably a polylactide; and (B) contacting the particulate deposited in the portion of the well with a treatment fluid comprising: (i) water; (ii) a source of a strong alkali; and (iii) a source of a strong oxidizer. The steps of depositing and contacting can be with a single treatment fluid or separate treatment fluids. | 12-18-2014 |
Vijaya Kumar Thommandru, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20090304755 | PHARMACEUTICAL FORMULATION OF LOSARTAN - A pharmaceutical composition comprising losartan and pharmaceutically acceptable salts thereof and a process of forming the same. The pharmaceutical composition of losartan comprises an active agent comprising an effective amount of losartan or its pharmaceutical salt thereof, and pharmaceutically acceptable additives, wherein d(0.9) of losartan is less than 50μ and/or specific surface area is more than 0.6 m | 12-10-2009 |
Vijaya Kumar Thommandru, Pune IN
Patent application number | Description | Published |
---|---|---|
20120077817 | NOVEL PHARMACEUTICAL COMPOSITIONS OF RANOLAZINE - A novel controlled release pharmaceutical dosage form comprising a therapeutically effective amount of ranolazine or pharmaceutically acceptable salt(s), polymorph(s), solvate(s), hydrate(s), enantiomer(s) thereof, one or more lipid(s) as release controlling agent(s) and one or more pharmaceutically acceptable excipient(s). | 03-29-2012 |
20130039957 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS OF BRIVARACETAM - The present invention relates to controlled release pharmaceutical compositions comprising Brivaracetam or its pharmaceutically acceptable derivatives thereof. Further disclosed is a controlled release pharmaceutical composition comprising a core and a coating surrounding the core, wherein the core comprises Brivaracetam or pharmaceutically acceptable derivative thereof and the coating comprises hydrophobic release controlling agent. The controlled release pharmaceutical composition comprises Brivaracetam or pharmaceutically acceptable derivatives thereof and hydrophobic release controlling agent, wherein said composition has dissolution of Brivaracetam at least 80% between about 7 to about 24 hours when measured in 900 ml of pH 6 phosphate buffer solution using USP apparatus type II, at 50 rpm and at 37° C. Also disclosed is a controlled release pharmaceutical composition useful for the treatment of epilepsy and treatment of symptomatic myoclonus comprises Brivaracetam or pharmaceutically acceptable derivative thereof and hydrophobic release controlling agent. | 02-14-2013 |
20130115246 | REDUCED DOSE ORAL PHARMACEUTICAL COMPOSITIONS OF FENOFIBRATE - The invention relates to reduced dose oral pharmaceutical composition of fenofibrate which exhibits substantial bioequivalence to Antara® Capsules under fasting condition and also capable of reducing the food effect on bioavailability of fenofibrate. Provided is a pharmaceutical composition comprising about 90 mg of fenofibrate particles having a D | 05-09-2013 |
20140161881 | REDUCED DOSE PHARMACEUTICAL COMPOSITIONS OF FENOFIBRATE - The present invention provides a reduced dose oral pharmaceutical composition comprising mixture of nanoparticulate fenofibrate and micronized fenofibrate and one or more pharmaceutically acceptable excipients. | 06-12-2014 |
Vijaya Kumar Vinukonda, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20160036441 | Output Signal Generation Circuitry for Converting an Input Signal From a Source Voltage Domain Into an Output Signal for a Destination Voltage Domain - Output signal generation circuitry | 02-04-2016 |
20160036445 | Receiver Circuitry and Method for Converting an Input Signal From a Source Voltage Domain Into an Output Signal for a Destination Voltage Domain - The present invention provides a receiver circuit and method for receiving an input signal from a source voltage domain and converting the input signal into an output signal for a destination voltage domain. The source voltage domain operates from a supply voltage that exceeds a stressing threshold of components within the receiver circuitry, and the receiver circuitry is configured to operate from the supply voltage of the source voltage domain. The receiver circuitry comprises first internal signal generation circuitry configured to convert the input signal into a first internal signal in a first voltage range, and second internal signal generation circuitry configured to convert the input signal into a second internal signal in a second voltage range. Signal evaluation circuitry establishes a logic high voltage threshold and a logic low voltage threshold dependent on the supply voltage, and employs the first and second internal signals in order to detect based on the logic high voltage threshold and logic low voltage threshold when the input signal transitions between a logic low level and a logic high level (in either direction). Output generation circuitry then generates the output signal in dependence on the detection performed by the signal evaluation circuitry. The first voltage range and the second voltage range are such that the first internal signal and second internal signal will not exceed the stressing threshold of components in the signal evaluation circuitry. The receiver circuitry is able to reliably detect transitions in the input signal in situations where the supply voltage of the source voltage domain exceeds the stressing threshold of the receiver's components, but without overstress of the receiver's components. | 02-04-2016 |